AlzChem Statistics
Share Statistics
AlzChem has 10.15M
shares outstanding. The number of shares has increased by 0.4%
in one year.
| 10.15M |
| 0.4% |
| 0% |
| n/a |
| 4.99M |
| n/a |
| n/a |
Short Selling Information
| n/a |
| n/a |
| n/a |
| n/a |
Valuation Ratios
The PE ratio is 10.65 and the forward
PE ratio is null.
AlzChem's PEG ratio is
0.19.
| 10.65 |
| n/a |
| 1.04 |
| n/a |
| 2.8 |
| 5.48 |
| 0.19 |
Financial Ratio History Enterprise Valuation
AlzChem has an Enterprise Value (EV) of 567.16M.
| 1.02 |
| 5.28 |
| 5.39 |
| 5.39 |
Financial Position
The company has a current ratio of 2.48,
with a Debt / Equity ratio of 0.26.
| 2.48 |
| 1.53 |
| 0.26 |
| 0.49 |
| 0.5 |
| 13.4 |
Financial Efficiency
Return on Equity is 26.31% and Return on Invested Capital is 14.5%.
| 26.31% |
| 11.18% |
| 14.5% |
| $359.66K |
| $35.09K |
| 1,541 |
| 1.15 |
| 1.93 |
Taxes
| 21.1M |
| 28% |
Stock Price Statistics
The stock price has increased by 266.5% in the
last 52 weeks. The beta is 0.82, so AlzChem's
price volatility has been higher than the market average.
| 0.82 |
| 266.5% |
| 92.78 |
| 61.43 |
| 50.09 |
| 5 |
Income Statement
In the last 12 months, AlzChem had revenue of 554.23M
and earned 54.08M
in profits. Earnings per share was 5.31.
| 554.23M |
| 360.73M |
| 78.13M |
| 54.08M |
| 107.49M |
| 81.17M |
| 5.31 |
Full Income Statement Balance Sheet
The company has 61.54M in cash and 52.82M in
debt, giving a net cash position of 8.72M.
| 61.54M |
| 52.82M |
| 8.72M |
| 186.84M |
| 483.83M |
| 156.4M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was 105.15M
and capital expenditures 0, giving a free cash flow of 105.15M.
| 105.15M |
| n/a |
| 105.15M |
| 10.33 |
Full Cash Flow Statement Margins
Gross margin is 65.09%, with operating and profit margins of 14.1% and 9.76%.
| 65.09% |
| 14.1% |
| 13.59% |
| 9.76% |
| 19.39% |
| 14.1% |
| 18.97% |